Laboratory for Bioregenerative Medicine and Surgery


Bioregenerative Technologies is a research-focused company specializing in tissue engineering, regenerative medicine, and innovative biomedical technologies. Their work includes developing 3D printed scaffolds, tissue regeneration techniques, and collaborations with leading surgeons and institutions to advance medical treatments and devices.

Industries

3d-printing
biotechnology
test-and-measurement

Nr. of Employees

small (1-50)

Laboratory for Bioregenerative Medicine and Surgery

New York, New York, United States, North America


Products

Autonomous Tissue Cartridge (miniature bioreactor with integrated imaging)

A self‑contained tissue cartridge designed as an autonomous bioreactor that enables controlled fabrication and maintenance of small engineered tissues with integrated imaging and direct control of parameters such as temperature and flow.

3D‑printed external auricular scaffolds with decellularized cartilage filler

Anatomically accurate, 3D-printed scaffolds combined with decellularized cartilage xenograft to generate full‑scale auricular constructs that preserve topography and biomechanical behavior during maturation.

3D‑printed bioabsorbable nipple scaffolds

Latticework, bioabsorbable polymer scaffolds with tunable porosity and filament geometry designed to maintain nipple projection and support tissue ingrowth over a targeted degradation timeline.

Low‑cost 3D‑printed perfusion bioreactor

A cost‑effective, 3D‑printed perfusion bioreactor platform designed to provide continuous flow and perfusion support for engineered tissues during in vitro culture.

Microfluidic perfusable vascular chips

Microfabricated chips that model tubular vasculature using engineered endothelial cells to study vessel formation, perfusability, and endothelial behavior in vitro.

Decellularized adipose and cartilage matrix production (collaborative projects)

Processes for producing decellularized cartilage and adipose matrices intended for off‑the‑shelf scaffolding and regenerative applications; includes collaborations evaluating supercritical CO2 decellularization and terminal sterilization methods.


Services

Preclinical implantation and in vivo evaluation

Small‑animal implantation studies to assess scaffold integration, tissue ingrowth, biomechanical properties, and long‑term maintenance of engineered constructs.

Expertise Areas

  • Tissue engineering and regenerative medicine
  • 3D printing and patient‑specific biofabrication
  • Vascularization and angiogenesis engineering
  • Decellularized matrix and xenograft processing
  • Show More (5)

Key Technologies

  • 3D printing / biofabrication
  • Decellularization of extracellular matrix
  • Microfluidic chip fabrication
  • Perfusion bioreactors
  • Show More (7)

Similar organizations

Browse all ORGANIZATIONS

JOIN OUR MAILING LIST

Stay Connected with MTEC

Keep up with active and upcoming solicitations, MTEC news and other valuable information.